1129470

Bi-Coastal Pharma International — FEI 3013263547

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Shrewsbury, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures